[Home](https://github.com/mm80843/T3.5/blob/main/docs/index.md) >> Class: [RiskMitigation](https://github.com/mm80843/T3.5/tree/main/docs/RiskMitigation/index.md) >> Individual ID:PBN__RiskMitigation_595 

# __ACE2 and TMPRSS2 inhibitors__

## Category to which it belongs

* [Efforts include RNA monitoring, occupant exposure modeling, targeted messages, adoption of principles, copper coating, and more.](https://github.com/mm80843/T3.5/blob/main/docs/PBNCategory/PBN__PBNCategory_304.md)

## Closest similar item

* [Implement advanced treatment processes, such as ozonation or membrane filtration, to improve removal efficiency of SARS-CoV-2 RNA.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_3043.md)
* [Continue research and development of vaccines against SARS-CoV-2.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_3065.md)
* [Improve specificity of PCR assays to distinguish between SARS-CoV-2 and other coronaviruses.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_3042.md)
* [Conduct research to understand the tissue tropism and pathogenesis of SARS-CoV-2.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_3062.md)
* [Development of drug therapies](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_1296.md)
* [Non-pharmaceutical interventions](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_377.md)
* [Utilize AI algorithms for drug discovery and development of novel treatments.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2860.md)
* [Conduct research to determine the mechanisms of cell entry and membrane fusion of SARS-CoV-2.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_3061.md)
* [Drug development](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_599.md)
* [Validate and optimize PCR assays to ensure accurate detection of SARS-CoV-2 genetic material.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_3041.md)

## Benefits linked to a risk

* [Pathogenesis](https://github.com/mm80843/T3.5/blob/main/docs/Benef/PBN__Benef_593.md)

## Risks possibly mitigated by this Mitigation

* [Tissue tropism](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_428.md)

